Skip to content

Clinical trials

Phase 3 Parkinson Disease trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 3 Country / region: Italy Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20042
20052
20063
20076
20081
20101
20131
20153
20162
20171
20182
20197
20203
20211
20222
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Terminated5
Active, not recruiting2
Recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie7
GlaxoSmithKline3
Impax Laboratories, LLC3
Theravance Biopharma3
UCB Pharma3
Boehringer Ingelheim2
Intec Pharma Ltd.2
Kyowa Kirin Co., Ltd.2
Solvay Pharmaceuticals2
Sumitomo Pharma America, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease42
Parkinsonian Disorders6
Dyskinesias5
Brain Diseases4
Central Nervous System Diseases4
Movement Disorders4
Nervous System Diseases4
Neurodegenerative Diseases4
Dizziness3
Hypotension3

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.